Coenzyme Q10 Supplementation Effect on Systemic Diseases
Aya Jabbar Hussein1 Show affiliations
- James L. Winkle College of Pharmacy, University of Cincinnati, United States
American Journal of Pharmacology and Toxicology, Volume 17, Issue 1, pp. 9–26 · doi.org/10.3844/ajptsp.2022.9.26
Abstract
This review paper aims to examine recent RandomizedClinical Trials (RCTs) and review articles evaluating the role of CoQ10 in themanagement of atherosclerosis, and coronary heart disease, with particularfocus on Statin-Associated Muscle Symptoms (SAMS), chronic heart failure, andthe effect on cardiovascular risk factors. With an evaluation of its impacts onpatients' well‐being, it seeks to outline the existing opportunities for usingCoQ10 in a multitude of cardiovascular, neurodegenerative, and metabolicdisorders.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Hussein, A. J. (2022). Coenzyme Q10 Supplementation Effect on Systemic Diseases. American Journal of Pharmacology and Toxicology, 17(1), 9–26. https://doi.org/10.3844/ajptsp.2022.9.26
- Licence
- CC BY 4.0
- Issue
- Volume 17, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record